Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

XYLO - Xylo Technologies Ltd. - ADR


Previous close
3.604
0   0%

Share volume: 2,607
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$3.60
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-4.43%
1 Month
-22.99%
3 Months
-34.66%
6 Months
29.70%
1 Year
-12.10%
2 Year
-59.38%
Key data
Stock price
$3.60
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$2.11 - $8.83
52 WEEK CHANGE
-$0.09
MARKET CAP 
13.212 M
YIELD 
N/A
SHARES OUTSTANDING 
3.829 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,554
AVERAGE 30 VOLUME 
$11,177
Company detail
CEO: Liron Carmel
Region: US
Website: http://www.medigus.com
Employees: 26
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

medical device company focused on innovative endoscopic procedures and devices. medigus developed an entire endoscopic system for intraluminal treatment of gerd (gastroesophageal reflux disease), one of the most common chronic diseases in the western world. the endoscopic system for the treatment of gerd - the srs - combines a miniaturized video camera, a surgical stapler and ultrasonic sights for alignment in a single instrument. the srs system and its unique flexible endoscope allows gastroenterologists and surgeons to perform endoluminally a true partial anterior fundoplication, thereby revolutionizing the treatment of gerd by eliminating the need for open or laparoscopic surgery - the current standard practice for treating severe gerd. shifting the gerd treatment from surgery to an endoluminal procedure, without opening the abdominal cavity, is a revolution. in addition, medigus designs and manufactures endoscopy systems for partner companies based on its proprietary technologies,

Recent news